Cart (0)
 
 

Home

ASX Market Wrap for Wednesday 21st February

FeaturedASX Market Wrap for Wednesday 21st February

The shifting face of Corporate Social Responsibility

FeaturedThe shifting face of Corporate Social Responsibility

Corporate Social Responsibility: a multidimensional challenge

FeaturedCorporate Social Responsibility: a multidimensional challenge

Submit Your Email now, and get
Our Latest update

NEWS

Fuse Minerals Limited (ASX:FSE) IPO

Floats & ListingsFundraisingNewsFuse Minerals Limited (ASX:FSE) IPO

April 4, 2024
Tasmea IPO

FundraisingNewsTasmea IPO

April 4, 2024
D3 Energy Limited listing on ASX

FundraisingNewsD3 Energy Limited listing on ASX

April 4, 2024
BlinkLab IPO

FundraisingNewsBlinkLab IPO

April 4, 2024
ABB’s legal action against Superloop

NewsABB’s legal action against Superloop

March 25, 2024
Your Company Share Price Performance

NewsYour Company Share Price Performance

March 25, 2024

FUNDRAISING

N/A Andrew and Shelley IPO Maintenance, engineering and sustaining capital service provider Tasmea Limited ASX Listing IPO Oil and Gas Exploration D3 Energy Limited BlinkLab was incorporated on 17 August 2021 for the purpose of accelerating the development and commercialisation of intellectual property developed at Princeton University relating to smartphone-neurobehavioral testing (Licenced IP). BlinkLab has the exclusive worldwide licence to commercialise the Licenced IP and has developed a smartphone-based application with an e-platform that serves as a medical device to perform neurometric tests to aid in the diagnosis of autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), schizophrenia and other neurodevelopmental conditions (BlinkLab Device). The tests include, but are not limited to, eyeblink conditioning (EBC), prepulse inhibition of acoustic startle (PPI) and habituation of eye blink response which serve as biomarkers for neurological and psychiatric disorders (BlinkLab Tests). The results from the BlinkLab Tests are recorded by smartphone and uploaded to BlinkLab’s confidential and secure online platform where the data is analysed using machine learning (ML). Upon admission, the primary focus of BlinkLab will be to complete the necessary regulatory clinical studies and obtain the necessary regulatory approvals (that being FDA approval in the US and CE Mark in Europe) to bring the BlinkLab Device to market initially as a diagnostic tool for ASD. Blinklab Limited IPO 1111 TestS NSX N/A this is a t test gold test Test Fundraising Dec 15 IPO N/A rights issue abc Rights Issue

ARTICLES

Does US Tax Overhaul Violate Global Trade Rules?

ArticlesDoes US Tax Overhaul Violate Global Trade Rules?

April 25, 2020
New Daring Street Style Trends Started by Gorgeous

ArticlesNew Daring Street Style Trends Started by Gorgeous

April 25, 2020
NPO Show Will Return for Spring 2020 Premiere

ArticlesNPO Show Will Return for Spring 2020 Premiere

April 25, 2020
Eco-Schools: educating new generations of eco warriors

ArticlesEco-Schools: educating new generations of eco warriors

February 25, 2024
The Oxygen Project – A global view from a tiny organism

ArticlesThe Oxygen Project – A global view from a tiny organism

February 25, 2024
Article Test 1

ArticlesArticle Test 1

April 25, 2019
test Article or lose top sections

Articlestest Article or lose top sections

April 25, 2019
This is the third test article of content

ArticlesThis is the third test article of content

April 25, 2019

AI Membership

AI Membership

$99.00
AI
Join Now

Home Loans and Finance

$0.00
Included in Membership
Join Now

Hotel Accomodation

$0.00
Included in Membership
Join Now

Car Hire

$0.00
Included in Membership
Join Now

Share trading

$0.00
Included in Membership
Join Now